1. Repository of OAI
Ελληνικά   English  

Browsing by Author Rizos, C. V.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 12 of 12
TitleAuthor(s)Issue date???itemlist.???
Are the pleiotropic effects of telmisartan clinically relevant?Rizos, C. V.; Elisaf, M. S.; Liberopoulos, E. N.24-Nov-2015-
Combining rosuvastatin with sartans of different peroxisome proliferator-activated receptor-gamma activating capacity is not associated with different changes in low-density lipoprotein subfractions and plasma lipoprotein-associated phospholipase ARizos, C. V.; Liberopoulos, E. N.; Tellis, C. C.; Florentin, M.; Elisaf, M. S.; Tselepis, A. D.24-Nov-2015-
Combining Rosuvastatin with Sartans of Different Peroxisome Proliferator-Activated Receptor-gamma Activating Capacity Is Not Associated with Different Changes in Low-Density Lipoprotein Subfractions and Plasma Lipoprotein-Associated Phospholipase A(2)Rizos, C. V.; Liberopoulos, E. N.; Tellis, C. C.; Florentin, M.; Elisaf, M. S.; Tselepis, A. D.24-Nov-2015-
Effect of Non-Statin Lipid Lowering and Anti-Obesity Drugs on LDL Subfractions in Patients with Mixed DyslipidaemiaFlorentin, M.; Tselepis, A. D.; Elisaf, M. S.; Rizos, C. V.; Mikhailidis, D. P.; Liberopoulos, E. N.24-Nov-2015-
The effect of simvastatin alone versus simvastatin plus ezetimibe on the concentration of small dense low-density lipoprotein cholesterol in subjects with primary hypercholesterolemiaFlorentin, M.; Liberopoulos, E. N.; Moutzouri, E.; Rizos, C. V.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
THE EFFECTS OF COMBINING ROSUVASTATIN WITH SARTANS OF DIFFERENT PPAR gamma ACTIVATING CAPACITY ON LOW-DENSITY LIPOPROTEIN SUBFRACTIONS AND LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A(2)Rizos, C. V.; Liberopoulos, E. N.; Tellis, C. C.; Florentin, M.; Elisaf, M. S.; Tselepis, A. D.24-Nov-2015-
Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in Greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: a 24-week, randomized, open-label, prospective studyRizos, C. V.; Milionis, H. J.; Kostapanos, M. S.; Florentin, M.; Kostara, C. E.; Elisaf, M. S.; Liberopoulos, E. N.24-Nov-2015-
Effects of thyroid dysfunction on lipid profileRizos, C. V.; Elisaf, M. S.; Liberopoulos, E. N.24-Nov-2015-
High-Density Lipoprotein Subclasses in Patients with or without the Metabolic SyndromeLagos, K. G.; Gazi, I. F.; Kostapanos, M. S.; Filippatos, T.; Kazakou, P. S.; Rizos, C. V.; Tselepis, A. D.; Elisaf, M.24-Nov-2015-
How safe is the use of thiazolidinediones in clinical practice?Rizos, C. V.; Elisaf, M. S.; Mikhailidis, D. P.; Liberopoulos, E. N.24-Nov-2015-
Pleiotropic effects of thiazolidinedionesRizos, C. V.; Liberopoulos, E. N.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Rosuvastatin treatment is associated with an increase in insulin resistance in hyperlipidaemic patients with impaired fasting glucoseKostapanos, M. S.; Milionis, H. J.; Agouridis, A. D.; Rizos, C. V.; Elisaf, M. S.24-Nov-2015-
Showing results 1 to 12 of 12